Table 2. NCCN criteria for referral for genetic risk evaluation for high-risk syndromes associated with CRC a .
1. Individuals meeting the Revised Bethesda Guidelines |
2. Individuals meeting the Amsterdam Criteria |
3. Individuals with >20 colorectal adenomas |
4. Individuals with multiple gastrointestinal hamartomatous polyps or serrated polyposis |
5. Individuals from a family with a known hereditary syndrome associated with CRC with or without a known mutation |
6. Individuals with desmoid tumor, cribriform morular variant of papillary thyroid cancer, or hepatoblastoma |
Abbreviation: CRC, colorectal cancer.
NCCN Clinical Practice Guidelines in Oncology Version 2.2015, nccn.org. 21